CN101862398B - Chinese medicament for treating osteoporosis - Google Patents
Chinese medicament for treating osteoporosis Download PDFInfo
- Publication number
- CN101862398B CN101862398B CN2009102354851A CN200910235485A CN101862398B CN 101862398 B CN101862398 B CN 101862398B CN 2009102354851 A CN2009102354851 A CN 2009102354851A CN 200910235485 A CN200910235485 A CN 200910235485A CN 101862398 B CN101862398 B CN 101862398B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- chinese
- radix
- parts
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 208000001132 Osteoporosis Diseases 0.000 title abstract description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 241001550206 Colla Species 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 241000209020 Cornus Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 230000001009 osteoporotic effect Effects 0.000 claims description 7
- 241000405414 Rehmannia Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 239000003292 glue Substances 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 230000000399 orthopedic effect Effects 0.000 abstract 1
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006742 locomotor activity Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating osteoporosis, belongs to the field of Chinese medicaments for treating orthopedic diseases, and has the aims of good effect and quick response. The Chinese medicament is prepared from the following raw materials such as deerhorn glue, notoginseng root, rehmanniae vaporata, glue of tortoise plastron, glossy ganoderma, Chinese wolfberry, Chinese angelica and the like, has the effects of strengthening the body resistance and archaeus, tonifying qi and nourishing blood, promoting blood circulation and removing blood stasis and enriching yin and nourishing kidney, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment orthopaedic disease.
Background technology
Present be intended to treat the osteoporotic field of Chinese medicines, exist the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that sufferers of osteoporosis face are owing to can not get the treatment of active drug for a long time in a large number, the state of an illness constantly develops, and the bone amount reduces, and bone strength weakens, and osteodynia is serious, easily fractures, and patient and family members thereof are very dissatisfied to this.
At problem set forth above, the invention provides the osteoporotic Chinese medicine of a kind of treatment, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the osteoporotic Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Colla cornus cervi 3-20 part Radix Notoginseng 3-20 part Radix Rehmanniae Preparata 5-40 part
Colla Plastri Testudinis 3-20 part Ganoderma 2-12 part Fructus Lycii 3-20 part
Radix Angelicae Sinensis 4-25 part
The osteoporotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Radix Rehmanniae Preparata, Fructus Lycii, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Colla cornus cervi, Colla Plastri Testudinis, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science is thought, all diseases of osteoporosis are sick at bone, control from kidney.It is Kidney-Yin to fill out to reuse the Radix Rehmanniae Preparata nourishing kidney in the event side, the Fructus Lycii liver and kidney tonifying, and replenishing vital essence to improve eyesight is to be principal agent; Be aided with the Ganoderma benefiting QI and nourishing blood, the body resistance strengthening and constitution consolidating; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling, assistant is with Colla Plastri Testudinis, Colla cornus cervi nourishing kidney, high replenishing vital essence and blood.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of enriching yin and nourishing kidney, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Colla cornus cervi 60 gram Radix Notoginseng 60 gram Radix Rehmanniaes Preparata 100 grams
Colla Plastri Testudinis 60 kairine sesames 40 gram Fructus Lyciis 60 grams
Radix Angelicae Sinensis 80 grams
Weight in accordance with regulations, with conventional water extraction process Radix Rehmanniae Preparata, Fructus Lycii, Radix Angelicae Sinensis are extracted, make extractum fine powder 72 grams, Colla cornus cervi, Radix Notoginseng, Colla Plastri Testudinis, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 1042 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Colla cornus cervi 100 gram Radix Notoginseng 100 gram Radix Rehmanniaes Preparata 200 grams
Colla Plastri Testudinis 100 kairine sesames 60 gram Fructus Lyciis 100 grams
Radix Angelicae Sinensis 130 grams
By above-mentioned same method, make 1746 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Colla cornus cervi 200 gram Radix Notoginseng 200 gram Radix Rehmanniaes Preparata 400 grams
Colla Plastri Testudinis 200 kairine sesames 120 gram Fructus Lyciis 200 grams
Radix Angelicae Sinensis 250 grams
By above-mentioned same method, make 3482 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
10 parts in 6 parts of Radix Rehmanniaes Preparata of 6 portions of Radix Notoginseng of Colla cornus cervi
6 parts of 4 portions of Fructus Lyciis of 6 portions of Ganodermas of Colla Plastri Testudinis
8 parts of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
30 parts in 12 parts of Radix Rehmanniaes Preparata of 15 portions of Radix Notoginseng of Colla cornus cervi
15 parts of 8 portions of Fructus Lyciis of 15 portions of Ganodermas of Colla Plastri Testudinis
18 parts of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science osteoporosis, through 11 routine clinical observations.Selecting the tcm diagnosis osteoporosis is standard: have a delicate constitution limb adynamia; Ache all over the body---lumbago and backache, hip pain, gonalgia, thorax pain, vertebrae percussion pain, height shortens, hunch, difficulty in walking.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 1 example, women's 10 examples do not have other serious disease, and the age is 59 years old-79 years old, 71.3 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and limbs are strong, and osteodynia is obviously alleviated from head to foot; The bone amount increases, and locomotor activity is better recovered.
2, effective: body constitution strengthens, and limbs are strong, and osteodynia is alleviated to some extent from head to foot; Locomotor activity is necessarily recovered.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.11 philtrums of clinical experiment, produce effects 5 people, effective 5 people, invalid 1 people, total effective rate 91.6%.
Claims (1)
1. the osteoporotic Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Colla cornus cervi 3---40 parts of 20 portions of Radix Notoginseng 3---20 parts of Radix Rehmanniaes Preparata 5---
Colla Plastri Testudinis 3---20 parts of 20 portions of Ganodermas 2---12 portions of Fructus Lyciis 3---
Radix Angelicae Sinensis 4---25 parts
The osteoporotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Radix Rehmanniae Preparata, Fructus Lycii, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Colla cornus cervi, Colla Plastri Testudinis, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354851A CN101862398B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354851A CN101862398B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating osteoporosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101862398A CN101862398A (en) | 2010-10-20 |
| CN101862398B true CN101862398B (en) | 2011-09-28 |
Family
ID=42954456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102354851A Expired - Fee Related CN101862398B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101862398B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552386B (en) * | 2012-02-14 | 2014-09-10 | 山东省中医药研究院 | Anti-osteoporosis Chinese medicinal preparation and preparation method thereof |
| CN104474131B (en) * | 2014-12-23 | 2018-02-09 | 刘西忠 | It is a kind of to be used to treat the medicine of bone amount reduction and osteoporosis caused by hepatopathy |
-
2009
- 2009-10-16 CN CN2009102354851A patent/CN101862398B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101862398A (en) | 2010-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843690B (en) | Chinese medicament for treating osteoporosis | |
| CN101862398B (en) | Chinese medicament for treating osteoporosis | |
| CN101564462B (en) | Chinese medicament for treating diabetic osteoporosis | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843741B (en) | Chinese medicament for treating femoral head necrosis | |
| CN101843731B (en) | Chinese medicament for treating femoral head necrosis | |
| CN101843739B (en) | Oral Chinese medicament for treating fracture | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843759B (en) | Oral Chinese medicament for treating fracture | |
| CN101843718B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843691B (en) | Chinese medicament for treating femoral head necrosis | |
| CN101843798B (en) | Oral Chinese medicament for treating fracture | |
| CN101843710B (en) | Chinese medicament for treating femoral head necrosis | |
| CN101843716B (en) | Chinese medicament for treating femoral head necrosis | |
| CN101843749A (en) | Chinese medicament for treating femoral head necrosis | |
| CN101843799B (en) | Oral Chinese medicament for treating fracture | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843776A (en) | Oral Chinese medicament for treating fracture | |
| CN101879245A (en) | Traditional Chinese medicine for treating femoral head necrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WEI DEZONG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20141218 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141218 Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui Patentee after: Wei Dezong Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Wei De Zong Document name: Notification of Termination of Patent Right |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20181016 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |